Skip to content

A study in healthy women to test whether BI 425809 influences the amount of a contraceptive in the blood

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-500050-42-00
Acronym
1346-0036
Enrollment
16
Registered
2022-11-10
Start date
2022-11-24
Completion date
2023-10-04
Last updated
2022-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026